Research and Markets Ltd
Stakeholder Insight: Infertility - Undifferentiated Drugs Force Need to Strengthen Prescriber and Payer Relationship
Published in Women's Health Weekly, February 26th, 2009
Over 11.5 million women suffer from infertility in the seven major markets. Although prevalence rates are stable, the trend towards later parenthood is inducing an increasing demand for infertility treatments. As cost of therapy is the major barrier access, the raise in demand puts increased pressure on healthcare payers to reimburse these treatments across the seven major markets.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Albert Einstein College of Medicine
Multivitamin use may offer no benefit in postmenopausal women - American Cancer Society
Black women with uterine cancers more likely to die than white patients - American Cancer Society
Pregnancy has no impact on breast cancer, but can delay diagnosis and treatment - American Society of Clinical Oncology
Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause - Cold Spring Harbor Laboratory
Camouflaging of viral DNA could be crucial step in progression of cancers - Massachusetts General Hospital
International study identifies gene variants associated with early heart attack - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
